What obesity drugmakers see next in the market: More pills, easier access and drug combinations ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
JPMorgan Healthcare Conference
since
auto-detected in 2 stories
35 days ago
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
44 days ago
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference ⊕
found
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
page 1 of 1